Idinvest Partners

Idinvest Partners

Idinvest Partners was founded in 1997 as the private equity division of Allianz France, initially named AGF Private Equity, and spun out as an independent partnership in 2010. CEO Christophe Bavière and Managing Partner Benoist Grossmann have led the firm since its early institutional days, steering its evolution from an insurance-owned captive into a diversified asset manager. The firm's origin inside a regulated insurer shaped its multi-strategy architecture and its sustained focus on European mid-market opportunities. The firm operates four principal strategies: growth capital for European technology companies, mid-market private equity buyouts, private debt and mezzanine financing, and venture capital. Its growth portfolio has backed companies including Deezer, Talend, and ManoMano, while its private debt arm has provided unitranche and senior financing to sponsor-backed deals across France, Germany, and the Benelux region. Idinvest commits capital through both primary fund structures and direct co-investment vehicles, with limited partners that include European pension funds, insurers, and sovereign wealth funds. The geographic focus is pan-European, with deal teams active from its Paris headquarters and deal flow across the continent. Idinvest reported approximately €10 billion in assets under management as of late 2019, prior to its acquisition by Eurazeo, a publicly listed investment company. Today the firm continues to manage its legacy fund portfolios while operating as a subsidiary brand within the Eurazeo group. The integration, completed in 2018, combined Idinvest's mid-market debt and growth equity capabilities with Eurazeo's large-cap buyout and brand-investing platform. Idinvest's professionals operate from Eurazeo's Paris offices, functioning as a distinct investment team within the broader organization. The architectural differentiator is Idinvest's permanent-capital lineage. Born inside an insurance company balance sheet, the firm developed an evergreen approach to fund management that resists the pressure to recycle into successive blind pools. That structure allowed the team to hold positions through multiple economic cycles without the forced exit timelines that constrain most independent general partners. Under Eurazeo, the platform retains that patient-capital ethos while accessing the parent company's listed-entity resources and institutional credibility.